Efficacy and safety of 5-grass pollen sublingual immunotherapy tablets in patients with different clinical profiles of allergic rhinoconjunctivitis

SUMMARY: BACKGROUND: The optimal dose of grass pollen tablets for sublingual immunotherapy (SLIT) in allergic rhinoconjunctivitis patients was previously established in a multinational, randomized, double-blind, placebo-controlled study in 628 adults. Patients were randomized to receive once-daily 5...

Descripción completa

Detalles Bibliográficos
Autores principales: Malling, H-J, Montagut, A, Melac, M, Patriarca, G, Panzner, P, Seberova, E, Didier, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2009
Materias:
Original Articles: Editor's Choice: Clinical Allergy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4233960/
https://www.ncbi.nlm.nih.gov/pubmed/19134019
http://dx.doi.org/10.1111/j.1365-2222.2008.03152.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4233960/
https://www.ncbi.nlm.nih.gov/pubmed/19134019
http://dx.doi.org/10.1111/j.1365-2222.2008.03152.x

Ejemplares similares